---
title: CDMO Daily News — August 18, 2026
slug: daily-news-2026-08-18-cdmo
site: cdmo
post_kind: news
byline: BioBM
description: August 18 CDMO daily: WuXi XDC Achieves GMP Release for Singapore Bioconjugate Production Line — WuXi XDC's Singapore GMP release expands APAC bioconjugate…
canonical_url: https://www.cdmo.directory/posts/daily-news-2026-08-18-cdmo
published_at: 2026-08-18T23:59:00.000Z
last_updated: 2026-08-19T02:25:23.644Z
---

### [WuXi XDC](/companies/wuxi-xdc) Achieves GMP Release for Singapore Bioconjugate Production Line
- [WuXi XDC](/companies/wuxi-xdc)'s Singapore BCM3 line achieved GMP release for antibody intermediates and conjugated drug substances, supporting batches up to 2,000 L.
- The facility represents WuXi XDC's first overseas GMP-released manufacturing site, completed in 2.5 years from design through qualification.
- A DP4 drug-product filling line at the same Singapore site is targeted for GMP release by end of August 2026.

**Operational Impact**

[WuXi XDC](/companies/wuxi-xdc)'s Singapore GMP release expands APAC bioconjugate manufacturing capacity and geographic redundancy, enabling commercial-scale dual sourcing for clients seeking regional supply-chain resilience.

*Source: [PharmaSource RSS](https://pharmasource.global/content/news/cdmo-news/wuxi-xdc-achieves-gmp-release-for-singapore-bioconjugate-production-line)*

## References

1. [PharmaSource RSS — WuXi XDC Achieves GMP Release for Singapore Bioconjugate Production Line](https://pharmasource.global/content/news/cdmo-news/wuxi-xdc-achieves-gmp-release-for-singapore-bioconjugate-production-line)

Source: https://www.cdmo.directory/posts/daily-news-2026-08-18-cdmo